Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group

Journal of Clinical Oncology

Volumn 32, Issue 13, 2014, Pages 1331-1337

  Orgel, Etan ^a,b,c   Sposto, Richard ^c,d   Malvar, Jemily ^c   Seibel, Nita L ^e   Ladas, Elena ^f   Gaynon, Paul S ^b,c   Freyer, David R ^b,c  

^a MILLER CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f Center for Comprehensive Wellness Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ASPARAGINASE; DAUNORUBICIN; HEMOPOIETIC GROWTH FACTOR; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BACTEREMIA; BODY WEIGHT DISORDER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; ERYTHROCYTE TRANSFUSION; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION; LIVER TOXICITY; LUNG TOXICITY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MYCOSIS; OBESITY; PANCREAS DISEASE; PANCREAS TOXICITY; PARENTERAL NUTRITION; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE TRANSFUSION; TIME TO TREATMENT; TOXICITY; TREATMENT RELATED TOXICITY; TREATMENT RESPONSE; UNDERWEIGHT; UNSPECIFIED SIDE EFFECT; BODY WEIGHT; COHORT ANALYSIS; DISEASE FREE SURVIVAL; INFANT; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL (TOPIC); TIME; YOUNG ADULT;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DAUNORUBICIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; MALE; OBESITY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THINNESS; TIME FACTORS; VINCRISTINE; YOUNG ADULT;

EID: 84902660266     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.52.6962     Document Type: Article

References (39)

1. Hunger SP, Lu X, Devidas M, et al: Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: A report from the Children's Oncology Group. J Clin Oncol 30:1663-1669, 2012
2. Gaynon PS, Angiolillo AL, Carroll WL, et al: Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: A Children's Oncology Group report. Leukemia 24:285-297, 2010
3. Pui CH, Campana D, Pei D, et al: Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360:2730-2741, 2009
4. Schultz KR, Pullen DJ, Sather HN, et al: Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: A combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood 109:926-935, 2007 (Pubitemid 46220635)
5. Butturini AM, Dorey FJ, Lange BJ, et al: Obesity and outcome in pediatric acute lymphoblastic leukemia. J Clin Oncol 25:2063-2069, 2007 (Pubitemid 46972792)
6. Lange BJ, Gerbing RB, Feusner J, et al: Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 293:203-203, 2005
7. Reilly JJ, Odame I, McColl JH, et al: Does weight for height have prognostic significance in children with acute lymphoblastic leukemia? Am J Pediatr Hematol Oncol 16:225-230, 1994
8. Gelelete CB, Pereira SH, Azevedo AM, et al: Overweight as a prognostic factor in children with acute lymphoblastic leukemia. Obesity (Silver Spring) 19:1908-1911, 2011
9. Hijiya N, Panetta JC, Zhou Y, et al: Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. Blood 108:3997-3997, 2006
10. Ethier MC, Alexander S, Abla O, et al: Association between obesity at diagnosis and weight change during induction and survival in pediatric acute lymphoblastic leukemia. Leuk Lymphoma 53:1677-1681, 2012
11. Weir J, Reilly JJ, McColl JH, et al: No evidence for an effect of nutritional status at diagnosis on prognosis in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 20:534-538, 1998 (Pubitemid 29135818)
12. Lobato-Mendizábal E, López-Martínez B, Ruiz-Argüelles GJ: A critical review of the prognostic value of the nutritional status at diagnosis in the outcome of therapy of children with acute lymphoblastic leukemia. Rev Invest Clin 55:31-35, 2003
13. Viana MB, Murao M, Ramos G, et al: Malnutrition as a prognostic factor in lymphoblastic leukaemia: A multivariate analysis. Arch Dis Child 71:304-310, 1994 (Pubitemid 24314615)
14. Withycombe JS, Post-White JE, Meza JL, et al: Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961. Pediatr Blood Cancer 53:1249-1254, 2009
15. Seibel NL, Steinherz PG, Sather HN, et al: Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group. Blood 111:2548-2555, 2008
16. Mei Z, Grummer-Strawn LM, Pietrobelli A, et al: Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents. Am J Clin Nutr 75:978-985, 2002 (Pubitemid 34547525)
17. Kuczmarski R, Ogden C, Grummer-Strawn L, et al: CDC growth charts: United States. Adv Data 8:1-27, 2000
18. Behan JW, Avramis VI, Yun JP, et al: Diet-induced obesity alters vincristine pharmacokinetics in blood and tissues of mice. Pharmacol Res 61:385-390, 2010
19. Zuccaro P, Guandalini S, Pacifici R, et al: Fat body mass and pharmacokinetics of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Ther Drug Monit 13:37-41, 1991
20. Thompson PA, Rosner GL, Matthay KK, et al: Impact of body composition on pharmacokinetics of doxorubicin in children: A Glaser Pediatric Research Network study. Cancer Chemother Pharmacol 64:243-251, 2009
21. Dunn TE, Ludwig EA, Slaughter RL, et al: Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity. Clin Pharmacol Ther 49:536-549, 1991
22. Mihranian MH, Wang YM, Daly JM: Effects of nutritional depletion and repletion on plasma methotrexate pharmacokinetics. Cancer 54:2268-2271, 1984 (Pubitemid 15210817)
23. Behan JW, Yun JP, Proektor MP, et al: Adipocytes impair leukemia treatment in mice. Cancer Res 69:7867-7874, 2009
24. Pramanik R, Sheng X, Ichihara B, et al: Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy. Leuk Res 37:503-509, 2013
25. Rickard KA, Detamore CM, Coates TD, et al: Effect of nutrition staging on treatment delays and outcome in stage IV neuroblastoma. Cancer 52:587-598, 1983 (Pubitemid 13025906)
26. Halton J, Scissons-Fisher C: Impact of nutritional status on morbidity and dose intensity of chemotherapy during consolidation therapy in children with acute lymphoblastic leukemia (ALL). J Pediatr Hematol Oncol 21:317, 1999 (abstr 311)
27. Capuano G, Grosso A, Gentile PC, et al: Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck 30:503-508, 2008 (Pubitemid 351578755)
28. Ladas EJ, Sacks N, Meacham L, et al: A multidisciplinary review of nutrition considerations in the pediatric oncology population: A perspective from Children's Oncology Group. Nutr Clin Pract 20:377-393, 2005 (Pubitemid 47050808)
29. Marchesini G, Moscatiello S, Di Domizio S, et al: Obesity-associated liver disease. J Clin Endocrinol Metab 93:S74-S80, 2008 (suppl 1)
30. Maggio AB, Mueller P, Wacker J, et al: Increased pancreatic fat fraction is present in obese adolescents with metabolic syndrome. J Pediatr Gastroenterol Nutr 54:720-726, 2012
31. Katona P, Katona-Apte J: The interaction between nutrition and infection. Clin Infect Dis 46:1582-1588, 2008 (Pubitemid 351706741)
32. Antillon F, Rossi E, Molina AL, et al: Nutritional status of children during treatment for acute lymphoblastic leukemia in Guatemala. Pediatr Blood Cancer 60:911-915, 2013
33. Ogden CL, Carroll MD, Kit BK, et al: Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 307:483-490, 2012
34. Caprio S, Daniels SR, Drewnowski A, et al: Influence of race, ethnicity, and culture on childhood obesity: Implications for prevention and treatment - A consensus statement of Shaping America's Health and the Obesity Society. Diabetes Care 31:2211-2221, 2008
35. Bhatia S, Sather HN, Heerema NA, et al: Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 100:1957-1964, 2002 (Pubitemid 35001223)
36. Baillargeon J, Langevin AM, Lewis M, et al: Obesity and survival in a cohort of predominantly Hispanic children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 28:575-578, 2006 (Pubitemid 44496334)
37. Warner JT, Cowan FJ, Dunstan FD, et al: The validity of body mass index for the assessment of adiposity in children with disease states. Ann Hum Biol 24:209-215, 1997
38. Warner JT, Evans WD, Webb DK, et al: Pitfalls in the assessment of body composition in survivors of acute lymphoblastic leukaemia. Arch Dis Child 89:64-68, 2004 (Pubitemid 38122016)
39. Wellens R, Roche AF, Guo S, et al: Fat-free mass and percent body fat assessments by dual-energy x-ray absorptiometry, densitometry and total body water. Basic Life Sci 60:71-74, 1993